Cunermuspir | 16230-63-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: Cunermuspir
• 英文别名: copper(1+);pyridine-3-carboxylate
• CAS: 16230-63-0
• 化学式: C6H4CuNO2
• 分子量: 185.65
• InChiKey: GJPYQIYQGMILDC-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  -0.56
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  53
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• Pure chelation process
  申请人：C LAB PHARMA INTERNATIONAL, S.A.

  公开号：US10258980B2

  公开（公告）日：2019-04-16

  The present invention relates to metal complexes and methods of synthesizing the metal complexes. The invention is further directed to pharmaceutical and/or dietary supplement composition comprising compounds synthesized as described herein.

  本发明涉及金属络合物和合成金属络合物的方法。本发明还涉及包含按本文所述方法合成的化合物的药物和/或膳食补充剂组合物。
• PURE CHELATION PROCESS
  申请人：C Lab Pharma International, S.A.

  公开号：EP3188835A1

  公开（公告）日：2017-07-12
• Copper(I) Chloride Complex Of Nicotinic Acid And Pharmaceutical Compositions Containing The Same
  申请人：Hussein Aly Ibraheim Salah Fathiy

  公开号：US20110274773A1

  公开（公告）日：2011-11-10

  A method for preparation pharmaceutical compounds in large quantities consists of copper (I) halide, preferably the chloride complex of nicotinic acid characterized by elemental analysis, spectroscopy and crystallographic methods, used for treatment of muscular dystrophy, myopathy, myasthenia gravis, parkinsonism, Chronic Fatigue Syndrome, Male Infertility and post stroke muscle weakness. Chlorobis (nicotinic acid) copper (I) monohydrate complex, its composition [CuCl (nicotinic acid)2]. H 2 O, has been prepared and its physical and chemical properties as well as its crystal structure have been investigated for the first time.
• METHOD FOR PREPARATION OF NICOTINIC ACID COPPER CHLORIDE COMPLEX, AND ITS PHARMACEUTICAL USES
  申请人：Hussein Aly Ibraheim Salah Fathiy

  公开号：US20130184247A1

  公开（公告）日：2013-07-18

  A method for preparation pharmaceutical compounds in large quantities consists of copper (I) halide, preferably the chloride complex of nicotinic acid characterized by elemental analysis, spectroscopy and crystallographic methods, used for treatment of muscular dystrophy, myopathy, myasthenia gravis, parkinsonism, Chronic Fatigue Syndrome, Male Infertility and post stroke muscle weakness. Chlorobis (nicotinic acid) copper (I) monohydrate complex, its composition [CuCl(nicotinic acid) 2 ]. H 2 O, has been prepared and its physical and chemical properties as well as its crystal structure have been investigated for the first time.
• [EN] PURE CHELATION PROCESS<br/>[FR] PROCÉDÉ DE CHÉLATION PUR
  申请人：C LAB PHARMA INTERNATIONAL S A

  公开号：WO2016037181A1

  公开（公告）日：2016-03-10

  The present invention relates to metal complexes and methods of synthesizing the metal complexes. The invention is further directed to pharmaceutical and/or dietary supplement composition comprising compounds synthesized as described herein.